Pure Bioscience Inc. | Income Statement
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
820.00
550.00
729.00
1,289.00
1,831.00
1,774
Cost of Goods Sold (COGS) incl. D&A
876.00
344.00
285.00
441.00
760.00
763
Gross Income
56.00
206.00
444.00
848.00
1,071.00
1,011
SG&A Expense
6,732.00
9,354.00
8,084.00
7,905.00
7,079.00
8,053
EBIT
6,788.00
9,148.00
7,640.00
7,057.00
6,008.00
7,042
Unusual Expense
283.00
2,082.00
5.00
7,348.00
277.00
478
Non Operating Income/Expense
7.00
190.00
16.00
44.00
22.00
870
Interest Expense
593.00
10.00
8.00
10.00
-
8
Pretax Income
7,671.00
11,050.00
7,627.00
14,371.00
6,263.00
7,442
Consolidated Net Income
7,671.00
11,050.00
7,627.00
14,371.00
6,263.00
7,442
Net Income
7,671.00
11,050.00
7,627.00
14,371.00
6,263.00
7,442
Net Income After Extraordinaries
7,671.00
11,050.00
7,627.00
14,371.00
6,263.00
7,442
Net Income Available to Common
7,671.00
11,050.00
7,627.00
14,371.00
6,263.00
7,442
EPS (Basic)
0.71
0.43
0.19
0.25
0.10
0.11
Basic Shares Outstanding
10,838.10
25,609.50
39,748.90
56,830.50
63,492.40
67,279.10
EPS (Diluted)
0.71
0.43
0.19
0.25
0.10
0.11
Diluted Shares Outstanding
10,838.10
25,609.50
39,748.90
56,830.50
63,492.40
67,279.10
EBITDA
6,477.00
8,900.00
7,434.00
6,838.00
5,732.00
6,757
About Pure Bioscience
View Profile
